Irish Bolster Applied Research

DUBLIN—The Irish government, after months of delay and speculation, has committed itself to a science and technology development program with a special emphasis on biotechnology. Although the Irish government is in the midst of making sharp cuts in public spending, Prime Minister Charles Haughey said this new allocation to develop science and technology "will be a permanent feature of the annual budget." Ireland spends about $600 million annually on science, a significant sum for a country

Written byKaren Birchard
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Ireland spends about $600 million annually on science, a significant sum for a country whose population is roughly the size of metropolitan Boston. At the same time, the figure falls considerably below the proportion of the gross national product spent on science by its European neighbors.

The Irish minister of state for science, Sean McCarthy, described the new program as "seed money," with much of it being spent on new instrumentation. McCarthy unveiled the $4 million program June 11, four months after the current government was elected. McCarthy is the country's first science minister, underlining the importance the new government has placed on science and technology.

The three universities in Cork, Galway and Dublin will set up "centers of excellence" in biotechnology under the new scheme, with programs in food biotechnology, diagnostics and cell culture. McCarthy said he hopes the biotechnology program will "expand significantly" in 1988.

Most of the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies